These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26802163)

  • 1. Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA).
    Barinka C; Ptacek J; Richter A; Novakova Z; Morath V; Skerra A
    Protein Eng Des Sel; 2016 Mar; 29(3):105-15. PubMed ID: 26802163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial design of an Anticalin directed against the extra-domain b for the specific targeting of oncofetal fibronectin.
    Gebauer M; Schiefner A; Matschiner G; Skerra A
    J Mol Biol; 2013 Feb; 425(4):780-802. PubMed ID: 23238252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput sorting of an Anticalin library via EspP-mediated functional display on the Escherichia coli cell surface.
    Binder U; Matschiner G; Theobald I; Skerra A
    J Mol Biol; 2010 Jul; 400(4):783-802. PubMed ID: 20630471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticalins directed against vascular endothelial growth factor receptor 3 (VEGFR-3) with picomolar affinities show potential for medical therapy and in vivo imaging.
    Richter A; Skerra A
    Biol Chem; 2017 Jan; 398(1):39-55. PubMed ID: 27458663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
    Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
    J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticalins small engineered binding proteins based on the lipocalin scaffold.
    Gebauer M; Skerra A
    Methods Enzymol; 2012; 503():157-88. PubMed ID: 22230569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide.
    Rauth S; Hinz D; Börger M; Uhrig M; Mayhaus M; Riemenschneider M; Skerra A
    Biochem J; 2016 Jun; 473(11):1563-78. PubMed ID: 27029347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disulfide-constrained peptides that bind to the extracellular portion of the prostate-specific membrane antigen.
    Lupold SE; Rodriguez R
    Mol Cancer Ther; 2004 May; 3(5):597-603. PubMed ID: 15141017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dimeric peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activity.
    Aggarwal S; Singh P; Topaloglu O; Isaacs JT; Denmeade SR
    Cancer Res; 2006 Sep; 66(18):9171-7. PubMed ID: 16982760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and characterization of canine prostate-specific membrane antigen.
    Schmidt S; Fracasso G; Colombatti M; Naim HY
    Prostate; 2013 May; 73(6):642-50. PubMed ID: 23359458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticalins directed against the fibronectin extra domain B as diagnostic tracers for glioblastomas.
    Albrecht V; Richter A; Pfeiffer S; Gebauer M; Lindner S; Gieser E; Schüller U; Schichor C; Gildehaus FJ; Bartenstein P; Tonn JC; Skerra A; Glass R
    Int J Cancer; 2016 Mar; 138(5):1269-80. PubMed ID: 26421425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen.
    Rajasekaran SA; Anilkumar G; Oshima E; Bowie JU; Liu H; Heston W; Bander NH; Rajasekaran AK
    Mol Biol Cell; 2003 Dec; 14(12):4835-45. PubMed ID: 14528023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is prostate-specific membrane antigen a multifunctional protein?
    Rajasekaran AK; Anilkumar G; Christiansen JJ
    Am J Physiol Cell Physiol; 2005 May; 288(5):C975-81. PubMed ID: 15840561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of monoclonal antibodies specific for protein conformational epitopes present in prostate-specific membrane antigen (PSMA).
    Tino WT; Huber MJ; Lake TP; Greene TG; Murphy GP; Holmes EH
    Hybridoma; 2000 Jun; 19(3):249-57. PubMed ID: 10952413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer.
    Han D; Wu J; Han Y; Wei M; Han S; Lin R; Sun Z; Yang F; Jiao D; Xie P; Zhang L; Yang AG; Zhao A; Wen W; Qin W
    Oncotarget; 2016 Sep; 7(37):59471-59481. PubMed ID: 27448970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticalins: exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins.
    Richter A; Eggenstein E; Skerra A
    FEBS Lett; 2014 Jan; 588(2):213-8. PubMed ID: 24239535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of MHC class II-restricted T-cell epitopes in prostate-specific membrane antigen.
    Schroers R; Shen L; Rollins L; Xiao Z; Sonderstrup G; Slawin K; Huang XF; Chen SY
    Clin Cancer Res; 2003 Aug; 9(9):3260-71. PubMed ID: 12960111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status.
    Lütje S; Heskamp S; Cornelissen AS; Poeppel TD; van den Broek SA; Rosenbaum-Krumme S; Bockisch A; Gotthardt M; Rijpkema M; Boerman OC
    Theranostics; 2015; 5(12):1388-401. PubMed ID: 26681984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer.
    Eder M; Schäfer M; Bauder-Wüst U; Haberkorn U; Eisenhut M; Kopka K
    Prostate; 2014 May; 74(6):659-68. PubMed ID: 24464532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer.
    Ganguly T; Dannoon S; Hopkins MR; Murphy S; Cahaya H; Blecha JE; Jivan S; Drake CR; Barinka C; Jones EF; VanBrocklin HF; Berkman CE
    Nucl Med Biol; 2015 Oct; 42(10):780-7. PubMed ID: 26169882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.